Gilenya Sales Data
| Rank 52 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Gilenya U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 52 ( 1) |
$272,701 | 4.05% | 64 | 4.92% |
| Q3 2013 | 53 ( 1) |
$262,083 | 0.49% | 61 | -1.61% |
| Q2 2013 | 52 (15) |
$260,801 | 10.75% | 62 | 10.71% |
| Q1 2013 | 67 (1) |
$235,496 | 1.18% | 56 | -1.75% |
| Q4 2012 | 66 (4) |
$232,746 | 5.17% | 57 | 3.64% |
| Q3 2012 | 70 (17) |
$221,299 | 21.19% | 55 | 12.24% |
| Q2 2012 | 87 ( ) |
$182,611 | n/a | 49 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
